Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
14 April 2022 | Story Jóhann Thormählen
Shimlas
Jooste Nel was one of the Shimla stars in 2022. The centre was chosen as the Player That Rocks against the Madibaz this week. Photo: ASEM Engage, Ian Fairley

It was their aim to entertain, and now the University of the Free State (UFS) Shimlas want to continue in the same vein in front of their home fans in the Varsity Cup semi-final that will be played on Shimla Park on the Bloemfontein Campus on Monday 18 April 2022 at 19:00.

According to Thabang Mahlasi, the Shimla captain, his side is excited to have a home advantage against the University of Pretoria (UP) Tuks and would like to reward their supporters by scoring more tries.

The Shimlas also got their faithful involved this week by launching an ‘Every Fellow’ campaign on social media to encourage supporters to stand together and sing the Shimla song.

One of the Shimlas’ biggest fans, Prof Francis Petersen, Rector and Vice-Chancellor of the UFS, says he will cheer on the team, wishing for another Varsity Cup trophy if the UFS reaches the final. “The UFS is home to top sports stars and winning the Varsity Rugby Cup – following our triumph in the Varsity Netball competition – will be great. Good luck to the team and know that every fellow Kovsie is behind you.”  

Big turnaround
The UFS defeated the Nelson Mandela University 72-24 in Gqeberha in its last league match this week to end first on the log. It was the fourth time in 2022 that the Shimlas scored 50 points or more.

This means they will host UP Tuks, who finished fourth, at Shimla Park on Monday, while the University of Cape Town and Stellenbosch University will play in Cape Town in the other semi-final.

The UFS play against the defending champions in the semi-final in what will be a tight affair. In a previous encounter with UP Tuks this month, Shimlas won 26-15.

It was quite a turnaround for the Shimlas, who finished seventh last year. It will be the first time since 2019 that they play in a semi-final.

“What a big confidence booster to play in front of our own supporters,” says Mahlasi.

“Apart from that, we don’t have to travel, which means our bodies will be fresh come Monday.”

He thanked the fans for their continued support and says, “they will be in for quite a show on Monday”.

Sign of unity
The Shimlas got their supporters behind them with a campaign on their Instagram page (@shimlasrugby). Fans can win money if they sing the Shimla song, ‘Every Fellow’, in a video, or use the audio with their favourite Shimla memory.

Mahlasi says the idea is to get fans to sing the song to motivate the team while playing.

“And also, after the game it would be nice if we could all stand and sing together. As a sign of unity.”

“Our main focus is scoring tries,” says Mahlasi.

“For us, it’s not about the semi-final. For us, it’s just another opportunity to score as many tries as we can.”

News Archive

Champagne and cancer have more in common than you might think
2013-05-08

 

Photo: Supplied
08 May 2013

No, a glass of champagne will not cure cancer....

…But they have more in common than you might think.

Researchers from the Departments of Microbial Biochemical and Food Biotechnology, Physics and the Centre for Microscopy at the University of the Free State in South Africa were recently exploring the properties of yeast cells in wine and food to find out more of how yeast was able to manufacture the gas that caused bread to rise, champagne to fizz and traditional beer to foam. And the discovery they made is a breakthrough that may have enormous implications for the treatment of diseases in humans.

The team discovered that they could slice open cells with argon gas particles, and look inside. They were surprised to find a maze of tiny passages like gas chambers that allowed each cell to ‘breathe.’ It is this tiny set of ‘lungs’ that puts the bubbles in your bubbly and the bounce in your bread.

But it was the technique that the researchers used to open up the cells that caught the attention of the scientists at the Mayo Clinic (Tumor Angiogenesis and Vascular Biology Research Centre) in the US.

Using this technology, they ultimately aim to peer inside cells taken from a cancer patient to see how treatment was progressing. In this way they would be able to assist the Mayo team to target treatments more effectively, reduce dosages in order to make treatment gentler on the patient, and have an accurate view of how the cancer was being eliminated.

“Yes, we are working with the Mayo Clinic,” said Profes Lodewyk Kock from the Microbial, Biochemical and Food Biotechnology Department at the UFS.

“This technique we developed has enormous potential for cell research, whether it is for cancer treatment or any other investigation into the working of cells. Through nanotechnology, and our own invention called Auger-architectomics, we are able to see where no-one has been able to see before.”

The team of Prof Kock including Dr Chantel Swart, Kumisho Dithebe, Prof Hendrik Swart (Physics, UFS) and Prof Pieter van Wyk (Centre for Microscopy, UFS) unlocked the ‘missing link’ that explains the existence of bubbles inside yeasts, and incidentally have created a possible technique for tracking drug and chemotherapy treatment in human cells.

Their work has been published recently in FEMS Yeast Research, the leading international journal on yeast research. In addition, their discovery has been selected for display on the cover page of all 2013 issues of this journal.

One can most certainly raise a glass of champagne to celebrate that!

There are links for video lectures on the technique used and findings on the Internet at:

1. http://vimeo.com/63643628 (Comic version for school kids)

2. http://vimeo.com/61521401 (Detailed version for fellow scientists)

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept